Loading market dashboard
So-Young International Inc.
SYHealthcareNASDAQCN
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
I lower my rating for So-Young International from 'Buy' to 'Hold' after analyzing its mixed 1Q2026 performance. 1Q2026 revenues surged 46% YoY, as the pivot towards offline aesthetic clinics paid off. But SY's net losses widened year-on-year in the first quarter due to lower contributions from high-margin online operations and costs relating to footprint expansion.
So-Young International Inc. (SY) Q1 2026 Earnings Call Transcript
So-Young International NASDAQ: SY reported sharply higher first-quarter 2026 revenue, driven by rapid growth in its branded aesthetic center business, while management said the company is continuing to expand its clinic footprint and invest in standardized medical delivery.
BEIJING, May 22, 2026 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced its unaudited financial results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Highlights Total revenues were RMB432.8 million (US$62.7 million[1]), compared with RMB297.3 million in the corresponding period of 2025.
So-Young to Report First Quarter 2026 Financial Results on May 22, 2026 PR Newswire BEIJING, May 14, 2026
BEIJING, May 14, 2026 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced that it will report its financial results for the first quarter ended March 31, 2026, before U.S. markets open on May 22, 2026. So-Young's management will hold an earnings conference call on Friday, May 22, 2026, at 7:30 AM U.S. Eastern Time (7:30 PM on the same day, Beijing/Hong Kong Time).
BEIJING, April 23, 2026 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the Securities and Exchange Commission on April 23, 2026. The annual report is available on the Company's investor relations website at https://ir.soyoung.com/.
So-Young International (NASDAQ: SY) used its fourth-quarter and full-year 2025 earnings call to outline what management described as a "strategic turning point" for 2026, as the company continues to scale its branded aesthetic center network while shifting focus toward improved profitability and operating efficiency. Industry backdrop and strategic focus Founder, Chairman, and CEO Xing Jin said
So-Young International Inc. (SY) Q4 2025 Earnings Call Transcript
BEIJING, March 25, 2026 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights Total revenues were RMB460.7 million (US$65.9 million[1]), compared with RMB369.2 million in the corresponding period of 2024.
BEIJING, March 10, 2026 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2025, before U.S. markets open on March 25, 2026. So-Young's management will hold an earnings conference call on Wednesday, March 25, 2026, at 7:30 AM U.S. Eastern Time (7:30 PM on the same day, Beijing/Hong Kong Time).
CVS Health (NYSE: CVS - Get Free Report) and So-Young International (NASDAQ: SY - Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, valuation, analyst recommendations, institutional ownership and dividends. Volatility and Risk CVS Health has a beta
Citigroup Inc. raised its holdings in So-Young International Inc. Sponsored ADR (NASDAQ: SY) by 1,301.9% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 675,121 shares of the company's stock after buying an additional 626,963 shares during the quarter. Citigroup Inc. owned
